Insider Trading History of Li Dean Y

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Li Dean Y since 2021. This trader's CIK number is 1837016. At the time of last reporting, Li Dean Y was the Executive VP & President, MRL of Merck & Co., Inc.. (stock ticker symbol MRK). Also see all insider trading activities at Merck & Co., Inc..

Note that in the past Li Dean Y also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Recursion Pharmaceuticals, Inc. (RXRX) by Li Dean Y

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2024 RXRX 0 $0 29,000 $401,331 0 $0
2021 RXRX 0 $0 35,000 $714,886 0 $0

Yearly summary of insider trading at Merck & Co., Inc. (MRK) by Li Dean Y

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2024 MRK 0 $0 14,702 $1,845,086 14,702 $912,553
2023 MRK 0 $0 0 $0 1,062 $122,629
2022 MRK 0 $0 0 $0 1,834 $161,853
2021 MRK 0 $0 0 $0 2,474 $185,340


Insider trading activities at 2 companies by Li Dean Y:

1. Recursion Pharmaceuticals, Inc. (RXRX)

2. Merck & Co., Inc. (MRK)

Table 1. Insider trading of Recursion Pharmaceuticals, Inc. (RXRX) by Li Dean Y

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2024-01-09 RXRX Sale 29,000 13.84 401,331
2021-12-07 RXRX Sale 15,900 20.75 329,925
2021-11-17 RXRX Sale 5,626 20.04 112,733
2021-11-19 RXRX Sale 13,474 20.20 272,228

Table 2. Insider trading of Merck & Co., Inc. (MRK) by Li Dean Y

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2024-02-09 MRK Option Ex 14,702 62.07 912,553
2024-02-09 MRK Sale 14,702 125.50 1,845,086
2023-05-01 MRK Option Ex 1,062 115.47 122,629
2022-05-03 MRK Option Ex 773 87.65 67,753
2022-05-01 MRK Option Ex 1,061 88.69 94,100
2021-05-04 MRK Option Ex 694 75.98 52,730
2021-05-01 MRK Option Ex 1,030 74.50 76,735
2021-05-03 MRK Option Ex 750 74.50 55,875

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Li Dean Y (Executive VP & President, MRL of Merck & Co., Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.